Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana-Farber Cancer Institute, Inc.filedCriticalDana-Farber Cancer Institute, Inc.
Priority claimed from PCT/US2013/053392external-prioritypatent/WO2014022758A1/en
Publication of HK1210481A1publicationCriticalpatent/HK1210481A1/zh
Publication of HK1210481BpublicationCriticalpatent/HK1210481B/zh
Method of assessing the efficacy of a test agent for modulating programmed death 1 (PD-1) signaling by using anti-phosphotyrosinylated PD-1 monoclonal antibodies